Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

The approval granted by the United States Food and Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc., USA, is for the strength of 10 mg/5 mg tablets, the generic version of Qtern tablets of the same strength of AstraZeneca AB, the company said in a statement.

from Moneycontrol Business News https://ift.tt/3d02wA2